AIM: To evaluate the efficacy of simple and extended cholecystectomy for mucosa (T1a) or muscularis (T1b) gallbladder (GB) cancer. METHODS: Original studies on simple and extended cholecystectomy for T1a or T1b GB cancer were searched from MEDLINE (PubMed), Cochrane Library, EMBase, and CancerLit using the search terms of GB, cancer/carcinoma/tumor/neoplasm. RESULTS: Twenty-nine out of the 2312 potentially relevant publications met the eligibility criteria. Of the 1266 patients with GB cancer included in the publications, 706 (55.8%) and 560 (44.2%) had T1a and T1b GB cancer, respectively. Simple cholecystectomy for T1a and T1b GB cancer was performed in 590 (83.6%) and 375 (67.0%) patients, respectively (P < 0.01). In most series, the treatment of choice was simple cholecystectomy for T1a GB cancer patients with a 5-year survival rate of 100%. Lymph node metastasis was detected in 10.9% of the T1b GB cancer patients and in 1.8% of the T1a GB cancer patients, respectively (P < 0.01). Eight patients (1.1%) with T1a GB cancer and 52 patients (9.3%) with T1b GB cancer died of recurrent GB cancer (P < 0.01). CONCLUSION: Simple cholecystectomy represents the adequate treatment of T1a GB cancer. There is no definite evidence that extended cholecystectomy is advantageous over simple cholecystectomy for T1b GB cancer.
AIM: To evaluate the efficacy of simple and extended cholecystectomy for mucosa (T1a) or muscularis (T1b) gallbladder (GB) cancer. METHODS: Original studies on simple and extended cholecystectomy for T1a or T1b GB cancer were searched from MEDLINE (PubMed), Cochrane Library, EMBase, and CancerLit using the search terms of GB, cancer/carcinoma/tumor/neoplasm. RESULTS: Twenty-nine out of the 2312 potentially relevant publications met the eligibility criteria. Of the 1266 patients with GB cancer included in the publications, 706 (55.8%) and 560 (44.2%) had T1a and T1b GB cancer, respectively. Simple cholecystectomy for T1a and T1b GB cancer was performed in 590 (83.6%) and 375 (67.0%) patients, respectively (P < 0.01). In most series, the treatment of choice was simple cholecystectomy for T1a GB cancerpatients with a 5-year survival rate of 100%. Lymph node metastasis was detected in 10.9% of the T1b GB cancerpatients and in 1.8% of the T1a GB cancerpatients, respectively (P < 0.01). Eight patients (1.1%) with T1a GB cancer and 52 patients (9.3%) with T1b GB cancer died of recurrent GB cancer (P < 0.01). CONCLUSION: Simple cholecystectomy represents the adequate treatment of T1a GB cancer. There is no definite evidence that extended cholecystectomy is advantageous over simple cholecystectomy for T1b GB cancer.
Authors: Gajanan D Wagholikar; Anu Behari; Narendra Krishnani; Ashok Kumar; Sadiq S Sikora; Rajan Saxena; Vinay K Kapoor Journal: J Am Coll Surg Date: 2002-02 Impact factor: 6.113
Authors: H Puhalla; T Wild; E Bareck; H Pokorny; M Ploner; T Soliman; S Stremitzer; D Depisch; F Laengle; T Gruenberger Journal: Eur J Surg Oncol Date: 2002-12 Impact factor: 4.424
Authors: H Shimada; I Endo; Y Fujii; N Kamiya; H Masunari; O Kunihiro; K Tanaka; K Misuta; S Togo Journal: Langenbecks Arch Surg Date: 2000-12 Impact factor: 3.445
Authors: Ji Hoon Park; Young Hoon Kim; Haeryoung Kim; Yoo-Seok Yoon; Young Rok Choi; Jai Young Cho; Yoon Jin Lee; Ho-Seong Han Journal: Surg Endosc Date: 2015-12-29 Impact factor: 4.584
Authors: Tak Geun Oh; Moon Jae Chung; Seungmin Bang; Seung Woo Park; Jae Bok Chung; Si Young Song; Gi Hong Choi; Kyung Sik Kim; Woo Jung Lee; Jeong Youp Park Journal: J Gastrointest Surg Date: 2013-01-09 Impact factor: 3.452
Authors: Jong Hee Yoon; Young Joo Lee; Song Cheol Kim; Jae Hoon Lee; Ki Byung Song; Ji Woong Hwang; Jeong Woo Lee; Dong Joo Lee; Kwang Min Park Journal: World J Surg Date: 2014-12 Impact factor: 3.352